| scholarly article | Q13442814 |
| P50 | author | Ayumu Taguchi | Q47331721 |
| Suhaida Selamat | Q56615909 | ||
| Ite Laird-Offringa | Q88912739 | ||
| P2093 | author name string | Qing Zhang | |
| Hong Wang | |||
| Muneesh Tewari | |||
| Jun Zhu | |||
| Adi F Gazdar | |||
| Carmen Behrens | |||
| Ignacio I Wistuba | |||
| Chee-Hong Wong | |||
| Samir M Hanash | |||
| Chenchen Yang | |||
| Alice Chin | |||
| Lisa McFerrin | |||
| Xudong Dai | |||
| Jaime Rodriguez | |||
| Jean P Thiery | |||
| Evan M Kroh | |||
| Muge Celiktas | |||
| Mark J Schliekelman | |||
| Kavita S Garg | |||
| P2860 | cites work | Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target | Q37389009 |
| Biological heterogeneity of cancer: implication to therapy | Q38031385 | ||
| The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity | Q38301987 | ||
| DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer | Q39409491 | ||
| Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition | Q39513776 | ||
| Epithelial-mesenchymal transition in tumor metastasis: a method to the madness | Q39936158 | ||
| Epithelium-mesenchyme interconversion as example of epithelial plasticity. | Q40821924 | ||
| Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. | Q46365315 | ||
| Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer | Q47635420 | ||
| Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer | Q48033732 | ||
| Control of cell behavior during vertebrate development by Slug, a zinc finger gene | Q48082697 | ||
| FGF Signaling Regulates Mesoderm Cell Fate Specification and Morphogenetic Movement at the Primitive Streak | Q52127589 | ||
| Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung. | Q54523390 | ||
| Evidence for a partial epithelial–mesenchymal transition in postnatal stages of rat auditory organ morphogenesis | Q63979925 | ||
| Changes in adhesive properties of epithelial cells during early morphogenesis of the mammary gland | Q74566337 | ||
| The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer | Q80502357 | ||
| Breaking down EMT | Q81556375 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination | Q24598602 | ||
| miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells | Q24613084 | ||
| Lung cancer signatures in plasma based on proteome profiling of mouse tumor models | Q24628852 | ||
| The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Molecular definition of breast tumor heterogeneity | Q28292256 | ||
| A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) | Q28296386 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Q29616071 | ||
| Molecular requirements for epithelial-mesenchymal transition during tumor progression | Q29618960 | ||
| Convergence of Wnt, beta-catenin, and cadherin pathways | Q29619504 | ||
| Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells | Q33648531 | ||
| Gene expression-based prognostic signatures in lung cancer: ready for clinical use? | Q33988433 | ||
| Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis | Q34004676 | ||
| A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment | Q34437862 | ||
| Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study | Q34798314 | ||
| A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. | Q35503722 | ||
| ZEB1-responsive genes in non-small cell lung cancer | Q35915752 | ||
| Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling | Q36090763 | ||
| Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis | Q36154999 | ||
| Modelling glandular epithelial cancers in three-dimensional cultures | Q36251934 | ||
| Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis | Q36467995 | ||
| Genetic heterogeneity of diffuse large B-cell lymphoma | Q36567845 | ||
| An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance | Q36597042 | ||
| The role of epithelial-mesenchymal transition in cancer pathology | Q36845018 | ||
| Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. | Q36902961 | ||
| Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung | Q37175519 | ||
| Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer | Q37343279 | ||
| EMT, the cytoskeleton, and cancer cell invasion | Q37377630 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 1789-1800 | |
| P577 | publication date | 2015-03-05 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival | |
| P478 | volume | 75 |
| Q94562094 | A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC |
| Q90186540 | A plausible accelerating function of intermediate states in cancer metastasis |
| Q93065118 | A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition |
| Q57043854 | Adducins inhibit lung cancer cell migration through mechanisms involving regulation of cell-matrix adhesion and cadherin-11 expression |
| Q92811815 | Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2+/- Mice |
| Q92214286 | An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation |
| Q36118557 | BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma |
| Q55690186 | Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated. |
| Q64940134 | Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications. |
| Q47154025 | Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines |
| Q33917675 | Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes |
| Q36557486 | Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma |
| Q91714177 | Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum |
| Q64880754 | Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis. |
| Q38823872 | Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells |
| Q36413140 | Coupling the modules of EMT and stemness: A tunable 'stemness window' model |
| Q59615849 | Distinguishing mechanisms underlying EMT tristability |
| Q33869775 | EMT and MET: necessary or permissive for metastasis? |
| Q61805560 | EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma |
| Q39130446 | Emerging Biological Principles of Metastasis |
| Q38696030 | Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer |
| Q98771757 | Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming |
| Q52540247 | Epithelial-mesenchymal transition and inflammation at the site of the primary tumor. |
| Q39395614 | Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease. |
| Q39339887 | Epithelial-to-mesenchymal transition in tumor progression |
| Q33869760 | Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding? |
| Q61812643 | Exosome-Mediated Signaling in Epithelial to Mesenchymal Transition and Tumor Progression |
| Q55426666 | Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response. |
| Q92000384 | Guidelines and definitions for research on epithelial-mesenchymal transition |
| Q64266936 | How apoptosis and epithelial-to-mesenchymal transition are nested in EGFR inhibitors resistance in lung cancer |
| Q88033641 | Hydrodynamic mobility of confined polymeric particles, vesicles, and cancer cells in a square microchannel |
| Q98384741 | Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis |
| Q91812815 | Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes |
| Q36710603 | Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. |
| Q26799987 | Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis |
| Q47948390 | In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer |
| Q91869765 | Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer |
| Q38435130 | Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space. |
| Q50926633 | MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway. |
| Q36821095 | MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition |
| Q91767631 | Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution |
| Q38804042 | Modeling continuum of epithelial mesenchymal transition plasticity. |
| Q36339995 | Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis |
| Q91869790 | Multi-sample deformability cytometry of cancer cells |
| Q33869781 | New insights into the role of EMT in tumor immune escape. |
| Q36966739 | Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. |
| Q38727049 | Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. |
| Q47162554 | Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. |
| Q36021039 | OVOL guides the epithelial-hybrid-mesenchymal transition. |
| Q41561954 | Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1. |
| Q39029043 | Pharmacological and immunological targeting of tumor mesenchymalization |
| Q35928957 | Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT |
| Q64890767 | Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. |
| Q38708958 | Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma |
| Q55008935 | Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. |
| Q55332965 | Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer. |
| Q37709301 | Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer |
| Q34519552 | Stability of the hybrid epithelial/mesenchymal phenotype |
| Q91518791 | Stem cell fate in cancer growth, progression and therapy resistance |
| Q47673602 | Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric |
| Q58734182 | TGF-β Signaling in Lung Health and Disease |
| Q39069234 | Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy |
| Q90587477 | Testing the gene expression classification of the EMT spectrum |
| Q65002297 | The Root Bark of Morus alba L. Suppressed the Migration of Human Non-Small-Cell Lung Cancer Cells through Inhibition of Epithelial⁻Mesenchymal Transition Mediated by STAT3 and Src. |
| Q64123052 | Towards control of cellular decision-making networks in the epithelial-to-mesenchymal transition |
| Q41317361 | Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer. |
| Q26748136 | Tumor Budding: The Name is EMT. Partial EMT |
| Q60932007 | Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549 |
| Q35898981 | ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer |
| Q36070381 | ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program |
| Q41354391 | ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion |
Search more.